Literature DB >> 2371545

Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population.

R Gustafson1, B Svenungsson, A Gardulf, G Stiernstedt, M Forsgren.   

Abstract

Sera from 346 individuals living on Lisö, an area south of Stockholm, endemic for tick-borne encephalitis (TBE) and Lyme borreliosis, were tested for antibody activity to TBE-virus (TBEV) and Borrelia burgdorferi, using a sonicate antigen, by haemagglutination-inhibition and ELISA, respectively. 10/346 (3%) individuals had a history of previous serologically confirmed TBE with encephalitic symptoms, and 33/346 (10%) had a history of previous erythema chronicum migrans (ECM). Four individuals (1%) had been treated for neuroborreliosis and another 4 (1%) for acrodermatitis chronica atrophicans (ACA). Antibodies to TBEV and B. burgdorferi were detected in 40/346 (12%) and 89/346 (26%) individuals, respectively. The seroprevalence of Lyme borreliosis increased with age, time spent on Lisö, and number of reported tick-bites. For TBE there was a correlation between seropositivity and time spent on Lisö only. In sera from 50 healthy blood-donors, living in a non-endemic area, no antibody activity to TBEV could be detected and only 1/50 (2%) had antibodies to borrelia. In sera from 150 age and sex matched control individuals, living in the city of Stockholm, antibody activity to TBEV and borrelia was found in 8/150 (5%) and 13/150 (9%), respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371545     DOI: 10.3109/00365549009027051

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  20 in total

1.  Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden.

Authors:  R Gustafson; B Svenungsson; M Forsgren; A Gardulf; M Granström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Seroprevalence of Lyme borreliosis in forestry workers from Brandenburg, Germany.

Authors:  P M Rath; B Ibershoff; A Mohnhaupt; J Albig; B Eljaschewitsch; D Jürgens; I Horbach; F J Fehrenbach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

Review 3.  Chronic Lyme disease.

Authors:  Paul M Lantos
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

4.  Lyme borreliosis--an overdiagnosed disease?

Authors:  B Svenungsson; G Lindh
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

Review 5.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Autoimmune-like syndromes during TNF blockade: does infection have a role?

Authors:  Joerg C Prinz
Journal:  Nat Rev Rheumatol       Date:  2011-03-29       Impact factor: 20.543

7.  2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

8.  A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Authors:  Nina Wressnigg; P Noel Barrett; Eva-Maria Pöllabauer; Maria O'Rourke; Daniel Portsmouth; Michael G Schwendinger; Brian A Crowe; Ian Livey; Thomas Dvorak; Bernhard Schmitt; Markus Zeitlinger; Herwig Kollaritsch; Meral Esen; Peter G Kremsner; Tomas Jelinek; Roland Aschoff; Roland Weisser; Ingomar F K Naudts; Gerald Aichinger
Journal:  Clin Vaccine Immunol       Date:  2014-09-03

9.  Genotypic and phenotypic analysis of Borrelia burgdorferi isolates from The Netherlands.

Authors:  L M Nohlmans; R de Boer; A E van den Bogaard; C P van Boven
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Prevalence of tick-borne encephalitis virus antibodies in dogs from Denmark.

Authors:  Katherine E S Lindhe; Danny S Meldgaard; Per M Jensen; Geoffrey A Houser; Mette Berendt
Journal:  Acta Vet Scand       Date:  2009-12-29       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.